美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Kailera Therapeutics, Inc.

26.00

+10.0062.50%

盘后：25.40-0.6000-2.31%19:59 EDT

成交量：811.43万

成交额：2.08亿

市值：30.67亿

市盈率：- -

高：27.50

开：26.00

低：23.70

收：16.00

52周最高：27.50

52周最低：23.70

股本：1.18亿

流通股本：3,333.33万

量比：- -

换手率：24.34%

股息：- -

股息率：- -

净资产收益率：-36.90%

总资产收益率：-22.73%

市净率：-8.60

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻资讯

异动解读 | 凯莱拉治疗公司盘中大涨62.5%，受益于纳斯达克成功上市及减肥药市场广阔前景

美股异动 | 减肥药新贵Kailera Therapeutics(KLRA.US)登陆美股市场开盘暴涨超50%

BUZZ-肥胖症药物开发商凯莱拉有望以高于发行价的价格在纳斯达克上市

募资6.25亿美元创五年之最减肥药新贵Kailera Therapeutics(KLRA.US)今晚登陆纳斯达克

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/KLRA"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KLRA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KLRA\",,,,,undefined,":{"symbol":"KLRA","market":"US","secType":"STK","nameCN":"Kailera Therapeutics, Inc.","latestPrice":26,"timestamp":1776456000000,"preClose":16,"halted":0,"volume":8114314,"hourTrading":{"tag":"盘后","latestPrice":25.4,"preClose":26,"latestTime":"19:59 EDT","volume":38738,"amount":996352.9387,"timestamp":1776470387477,"change":-0.6,"changeRate":-0.023077,"amplitude":0.047308},"delay":0,"changeRate":0.625,"floatShares":33333334,"shares":117948773,"eps":0,"marketStatus":"未开盘","change":10,"latestTime":"04-17 16:00:00 EDT","open":26,"high":27.5,"low":23.7,"amount":208032997.18292,"amplitude":0.2375,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1776672000000},"marketStatusCode":0,"adr":0,"listingDate":1776398400000,"exchange":"NASDAQ","adjPreClose":16,"postHourTrading":{"tag":"盘后","latestPrice":25.4,"preClose":26,"latestTime":"19:59 EDT","volume":38738,"amount":996352.9387,"timestamp":1776470387477,"change":-0.6,"changeRate":-0.023077,"amplitude":0.047308},"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KLRA\",,,,,undefined,":{"symbol":"KLRA","floatShares":33333334,"roa":"-22.73%","roe":"-36.90%","lyrEps":0,"shares":117948773,"dividePrice":0,"high":27.5,"amplitude":0.2375,"preClose":16,"low":23.7,"week52Low":23.7,"pbRate":"-8.60","week52High":27.5,"institutionHeld":0,"latestPrice":26,"eps":0,"divideRate":0,"volume":8114314,"delay":0,"ttmEps":0,"open":26,"prevYearClose":16,"prevWeekClose":16,"prevMonthClose":16,"prevQuarterClose":16,"fiveDayClose":16,"twentyDayClose":16,"sixtyDayClose":16},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KLRA\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KLRA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KLRA\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/KLRA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"KLRA","date":"2026-04-17","current":-12.669466,"percent":0,"low":-12.669466,"twenty":-12.511098,"median":-12.273546,"eighty":-12.035993,"high":-11.877625,"avg":-12.273546,"sd":0.39592,"marketCap":1887180368},"quantilePoints":[{"date":"2026-04-17","current":-12.669466,"twenty":-12.511098,"median":-12.273546,"eighty":-12.035993,"marketCap":1887180368}],"updateTime":1776617363435},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KLRA\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1136289592","title":"异动解读 | 凯莱拉治疗公司盘中大涨62.5%，受益于纳斯达克成功上市及减肥药市场广阔前景","url":"https://stock-news.laohu8.com/highlight/detail?id=1136289592","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136289592?lang=zh_cn&edition=fundamental","pubTime":"2026-04-18 01:27","pubTimestamp":1776446849,"startTime":"0","endTime":"0","summary":"凯莱拉治疗公司今日盘中股价大幅上涨62.50%，引起了市场的广泛关注。此次股价大涨与公司成功登陆纳斯达克密切相关。消息显示，凯莱拉治疗公司首次公开募股以每股16美元的价格发行，而市场预期其开盘价将达到32美元，远高于发行价，这反映了投资者对公司的高度认可和强烈兴趣。凯莱拉治疗公司的主要候选产品ribupatide作为一种每周注射一次的GLP-1药物，目前正处于后期试验阶段，这进一步增强了市场对其未来商业化前景的信心。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["KLRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628578522","title":"美股异动 | 减肥药新贵Kailera Therapeutics(KLRA.US)登陆美股市场 开盘暴涨超50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628578522","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628578522?lang=zh_cn&edition=fundamental","pubTime":"2026-04-18 00:00","pubTimestamp":1776441606,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周五，减肥药新贵Kailera Therapeutics(KLRA.US)登陆美股市场，开盘暴涨超50%，报24.1美元，IPO价格为16美元。该公司创下2021年以来美国生物科技领域规模最大的IPO纪录。Kailera成立于2024年，是一家处于临床后期的生物科技公司，正在开发四种基于GLP-1的减肥药物，其中包括一款每周注射一次的药物和一款每日口服一次的药片，目前均已进入后期临床试验阶段。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1430273.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4007","BK4139","KLRA","LENZ","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628423202","title":"BUZZ-肥胖症药物开发商凯莱拉有望以高于发行价的价格在纳斯达克上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2628423202","media":"路透中文","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628423202?lang=zh_cn&edition=fundamental","pubTime":"2026-04-17 22:16","pubTimestamp":1776435384,"startTime":"0","endTime":"0","summary":"** 减肥药开发商Kailera Therapeutics KLRA.O在纳斯达克首次上市的开盘价有望高于发行价** 最近表示股票开盘价为每股32美元，而发行价为16美元** 总部位于马萨诸塞州沃尔瑟姆市的KLRA在首次公开募股中以每股14-16美元的最高价出售了3,910万股股票 ，募集资金6.25亿美元。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260417:nL4S41018P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGXZ57979304.SGD","LU1066051498.USD","LU0225771236.USD","BK4588","BK4007","BK4599","BK4581","IE00B19Z3581.USD","LU0985481810.HKD","LU1894683348.USD","KLRA","LU0868494617.USD","SG9999011175.SGD","BK4127","LU0289739699.SGD","LU1894683264.USD","LU0456855351.SGD","LU0058720904.USD","LU1057294990.SGD","LU1023059063.AUD","SG9999001176.USD","LU0321505868.SGD","BK4585","BK4592","IE000M9KFDE8.USD","BK4534","LU0225284248.USD","BK4568","BK4533","LU1066053197.SGD","IE00BLSP4239.USD","IE0002270589.USD","SG9999002224.SGD","LU0122379950.USD","BK4550","BK4207","LU0306806265.USD","LU1883839398.USD","SG9999002232.USD","SG9999001176.SGD","LU0306807586.USD","SG9999003800.SGD","SG9999013999.USD","IE00B19Z3B42.SGD","LU0321505439.SGD","LU0170899867.USD","IE00BLSP4452.SGD","LU0234572021.USD","IE00BBT3K403.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628221198","title":"募资6.25亿美元创五年之最 减肥药新贵Kailera Therapeutics(KLRA.US)今晚登陆纳斯达克","url":"https://stock-news.laohu8.com/highlight/detail?id=2628221198","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628221198?lang=zh_cn&edition=fundamental","pubTime":"2026-04-17 11:33","pubTimestamp":1776396818,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，专注于肥胖症治疗的临床阶段生物科技公司Kailera Therapeutics Inc.通过扩大首次公开发行规模，成功募资6.25亿美元，创下2021年以来美国生物科技领域规模最大的IPO纪录。根据周四发布的一份声明，Kailera以每股16美元的价格出售了约3900万股股票。包括贝恩资本旗下Bain Capital Private Equity、Bain Capital Life Sciences和卡塔尔投资局在内的现有股东已表示，有意按IPO价格合计购买最多2.25亿美元的公司股票。此次IPO之前，Kailera已于去年10月通过B轮融资募资6亿美元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1429802.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["NVIW.SI","KLRA","QLD","PSQ","QQQE","BK4007","SQQQ","IYW","QQQJ","QQQA","QDTE","TQQY","QQQY","QQQM","QQQ","QID","GPIQ","FTEC","TQQQ","QYLG","BK1147","MNQmain","BK4539","JEPQ","BK4139","ONEQ"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":5,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/KLRA\",params:#limit:6,delay:false,,,undefined,":[]}}